Nalaganje...

A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer

A systematic review was performed to evaluate the clinical effectiveness of docetaxel in combination with prednisolone (docetaxel is licensed in the UK for use in combination with prednisone or prednisolone for the treatment of patients with metastatic hormone-refractory prostate cancer. Prednisone...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Collins, R, Trowman, R, Norman, G, Light, K, Birtle, A, Fenwick, E, Palmer, S, Riemsma, R
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2006
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360673/
https://ncbi.nlm.nih.gov/pubmed/16880788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603287
Oznake: Označite
Brez oznak, prvi označite!